Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
3,294
Funds Holding Change
+4
Funds Holding Growth
+0.1%
Value
$1.01T
Holding in Top 10
1,066
Top 10 Change
-88
Top 10 Growth
-8%
Value Growth
-0.1%
New
98
Increased
1,490
Reduced
1,526
Closed
60
Capital Inflow
$31.9B
Capital Outflow
$26.7B
Net Capital Flow
+$5.13B
Capital Flow Change
+$6.95B
Calls
$10.3B
Puts
$11.6B
Net Calls
-$1.37B
Put/Call Ratio
1.13